Chatenay Malabry, France

Serguei Nabirochkin

USPTO Granted Patents = 52 

 

 

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 205(Granted Patents)

Forward Citations (Not Self Cited) = 25(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Catenay Malabry, FR (2020)
  • Chateney-Malabry, FR (2020)
  • Chatenay Malabry, FR (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Charcot-Marie-Tooth Disease
Alzheimer's Disease
Neurological Disorders
Amyotrophic Lateral Sclerosis
Diabetes Treatment
Cerebral Ischemia
Nootropic Compositions
Parkinson's Disease
Angiogenesis Modulation
Synapse Function
Biomarkers Detection
Therapeutic Approaches
52 patents (USPTO):Explore Patents

Title: Serguei Nabirochkin: Innovator in Charcot-Marie-Tooth Disease Research

Introduction

Serguei Nabirochkin, located in Chatenay Malabry, France, is a prominent inventor with an impressive portfolio of 52 patents. His work primarily focuses on innovations in medical treatments, particularly in addressing Charcot-Marie-Tooth Disease (CMT), a group of inherited disorders that affect the peripheral nerves.

Latest Patents

Among his latest innovations are two significant patents that aim to improve the lives of those afflicted by CMT. The first patent outlines methods for treating, preventing, or delaying the onset of Charcot-Marie-Tooth Disease type 1A (CMT1A). This method involves administering a combination of baclofen, sorbitol, and naltrexone, or a pharmaceutically acceptable salt thereof, to subjects in need. The second patent relates to compositions and methods for treating CMT and related disorders, showcasing his dedication to advancing medical science in this field.

Career Highlights

Serguei Nabirochkin has established a noteworthy career at Pharnext, where he has played a pivotal role in developing therapies for neurological conditions. His extensive work has not only contributed to the scientific community but also has the potential to benefit countless individuals suffering from CMT.

Collaborations

Throughout his career, Nabirochkin has collaborated with accomplished colleagues, including Daniel Cohen and Ilya Chumakov. This collaborative spirit fosters an environment of innovation and enhances the likelihood of successful breakthroughs in treatment methodologies.

Conclusion

Serguei Nabirochkin's significant contributions to the field of medicine highlight the vital role inventors play in advancing healthcare. Through his innovative patents, he continues to lead the way in finding solutions for Charcot-Marie-Tooth Disease, exemplifying the impact of dedication and creativity in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…